OverviewSuggest Edit

Novavax is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. The Company, through its recombinant nanoparticle vaccine technology, produces vaccine candidates to respond to both known and newly emerging diseases. Novavax's product pipeline focuses on a range of infectious diseases with vaccine candidates in clinical development for respiratory syncytial virus, seasonal influenza, pandemic influenza and the Ebola virus.

TypePublic
Founded1987
HQGaithersburg, MD, US
Websitenovavax.com
Employee Ratings3.8
Overall CultureD

Latest Updates

Employees (est.) (Sept 2019)168(-45%)
Job Openings162
Revenue (FY, 2020)$475.6 M(+2449%)
Share Price (Jul 2021)$209.9
Cybersecurity ratingBMore

Key People/Management at Novavax

Stanley C. Erck

Stanley C. Erck

Director, President and CEO
Frank Czworka

Frank Czworka

Senior Vice President, Sales
Gregory M. Glenn

Gregory M. Glenn

President, Research and Development
Filip Dubovsky

Filip Dubovsky

Executive Vice President, Chief Medical Officer
Rick Crowley

Rick Crowley

Executive Vice President, Chief Operations Officer
John A. Herrmann

John A. Herrmann

Executive Vice President, Chief Legal Officer
Show more

Novavax Office Locations

Novavax has offices in Gaithersburg, Jevany and Uppsala
Gaithersburg, MD, US (HQ)
21 Firstfield Rd
Jevany, CZ
Bohumil 138
Uppsala, SE
109 Kungsgatan
Show all (3)

Novavax Financials and Metrics

Novavax Revenue

Novavax's revenue was reported to be $475.6 m in FY, 2020
USD

Revenue (Q1, 2021)

447.2m

Net income (Q1, 2021)

(222.7m)

EBIT (Q1, 2021)

(208.6m)

Market capitalization (22-Jul-2021)

15.6b

Closing stock price (22-Jul-2021)

209.9

Cash (31-Mar-2021)

2.0b

EV

13.9b
Novavax's current market capitalization is $15.6 b.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

14.7m22.1m20.9m30.7m36.3m15.4m31.2m34.3m18.7m475.6m

Revenue growth, %

4182%50%(5%)47%18%(58%)

Cost of goods sold

7.0m14.7m8.2m15.0m

Gross profit

7.7m7.4m12.7m15.7m
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q1, 2021

Revenue

3.0m5.0m4.6m7.1m5.8m3.8m3.5m4.8m7.5m8.3m8.2m9.9m14.0m6.5m4.2m2.5m3.2m5.7m6.7m8.4m9.7m10.8m7.7m4.0m3.4m2.5m3.4m35.5m447.2m

Cost of goods sold

3.8m5.1m3.8m1.7m1.6m2.3m3.0m5.1m2.5m2.7m2.7m

Gross profit

856.0k2.0m1.9m2.1m1.9m2.5m4.4m3.2m7.4m11.3m3.8m

Gross profit Margin, %

18%28%33%55%54%53%60%38%75%81%58%
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Cash

14.1m17.4m119.5m32.3m93.1m144.4m106.3m70.2m78.8m553.4m

Accounts Receivable

2.0m1.0m1.9m7.5m2.3m233.0k7.5m262.0m

Prepaid Expenses

2.4m2.6m17.8m16.3m8.0m181.3m

Inventories

9.2m19.3m21.8m
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Net Income

(19.4m)(28.5m)(52.0m)(82.9m)(156.9m)(280.0m)(183.8m)(184.7m)(132.7m)(418.3m)

Depreciation and Amortization

1.6m1.7m2.6m4.4m6.0m8.5m9.8m8.2m5.7m4.9m

Accounts Payable

(2.7m)2.0m4.2m14.0m9.1m(4.8m)5.2m(6.7m)(11.5m)163.2m

Cash From Operating Activities

(23.6m)(18.2m)(45.4m)(87.1m)60.8m(255.5m)(138.7m)(184.8m)(136.6m)(42.5m)
USDQ2, 2011

Financial Leverage

1.2 x
Show all financial metrics

Novavax Operating Metrics

FY, 2016

Patents (US)

250

Phase I Trials Products

2

Phase II Trials Products

1

Phase III Trials Products

1
Show all operating metrics

Novavax Cybersecurity Score

Cybersecurity ratingPremium dataset

B

89/100

SecurityScorecard logo

Novavax Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

CSRHub logo

Novavax Online and Social Media Presence

Embed Graph

Novavax Company Culture

  • Overall Culture

    D

    63/100

  • CEO Rating

    D+

    63/100

  • Compensation

    C-

    61/100

Learn more on Comparably

Novavax News and Updates

Why Novavax Stock Should Continue To Rally

Novavax stock has rallied by almost 12% over the last week (five trading days), compared to the S&P 500 which was down by almost 3% over the same period. The stock is also up by a solid 85% year-to-date. The recent outperformance comes on the back of a broader rally in Covid vaccine stocks...

Can Novavax Rise To The Manufacturing Challenge?

Novavax published results of its U.S. phase 3 trials for its Covid-19 vaccine in mid-June, noting that the shot was over 90% effective overall and 100% effective against moderate and severe disease, roughly in line with Covid vaccine leaders such as Pfizer and Moderna. Although the shot is likely...

Novavax And Lowe’s Among Today’s Trending Stocks

Q.ai runs daily factor models to get the most up-to-date reading on stocks and ETFs. Today, our deep-learning algorithms have identified Novavax and Lowe's among others.

Thinking about trading options or stock in Sunrun, Trade Desk, Novavax, Ford, or Bank of America?

NEW YORK, June 17, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for RUN, TTD, NVAX, F, and BAC. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report – Ideal trade ideas on up to seven different...

Thinking about trading options or stock in Draftkings, GameStop, Freeport-McMoRan, Novavax, or Cleveland-Cliffs?

NEW YORK, June 15, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DKNG, GME, FCX, NVAX, and CLF. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report – Ideal trade ideas on up to seven different...

Artificial Intelligence Identifies Novavax, Inc Among Today’s Trending Stocks

Q.ai runs daily factor models to get the most up-to-date reading on stocks and ETFs. Today, our deep-learning algorithms have identified Novavax Inc and Salesforce.com among others.
Show more

Novavax Blogs

Novavax Publishes Results of United Kingdom Phase 3 Clinical Trial in New England Journal of Medicine, Demonstrating High Levels of Efficacy of COVID-19 Vaccine

- Publication of final analysis highlights the robust safety and efficacy data of NVX-CoV2373 in large, pivotal placebo-controlled trial

Novavax Statement on Completion of the National Research Council of Canada Biologics Manufacturing Centre

Novavax Statement on Completion of the National Research Council of Canada Biologics Manufacturing Centre jhansen@novavax.com Tue, 06/22/2021 - 14:56 Novavax Statement on Completion of the National Research Council of Canada Biologics Manufacturing Centre Jun 22, 2021 at 2…

Novavax to Participate in Fireside Chat at SVB Leerink CybeRx Series: Vaccine Forum

GAITHERSBURG, Md. , June 17, 2021 /PRNewswire/ --  Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it will participate in a fireside chat during the upcoming 2 nd Annual CybeRx Series: Vaccine Forum .

Novavax to Participate in National Vaccine Advisory Committee Meeting

GAITHERSBURG, Md. , June 17, 2021 /PRNewswire/ --  Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that Gregory M. Glenn , M.D., President, Research and Development, will participate in a session during the
Show more

Novavax Frequently Asked Questions

  • When was Novavax founded?

    Novavax was founded in 1987.

  • Who are Novavax key executives?

    Novavax's key executives are Stanley C. Erck, Frank Czworka and Gregory M. Glenn.

  • How many employees does Novavax have?

    Novavax has 168 employees.

  • What is Novavax revenue?

    Latest Novavax annual revenue is $475.6 m.

  • What is Novavax revenue per employee?

    Latest Novavax revenue per employee is $2.8 m.

  • Who are Novavax competitors?

    Competitors of Novavax include Proteus Digital Health, Wren Therapeutics and CosmosID.

  • Where is Novavax headquarters?

    Novavax headquarters is located at 21 Firstfield Rd, Gaithersburg.

  • Where are Novavax offices?

    Novavax has offices in Gaithersburg, Jevany and Uppsala.

  • How many offices does Novavax have?

    Novavax has 3 offices.